Liquid Biopsy Market Worth US$ 2 Billion by 2022

New York, April 24: Market Research Engine has published a new report titled as “Liquid Biopsy Market By Type of Cancer Analysis (Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Liver Cancer); By Product and services Analysis (Instruments, Services and Software, Reagents); By Circulation Biomarkers Analysis (Circulating Tumor Cells (CTCs), Extracellular Vesicles (EVs), Circulating Tumor DNA (ctDNA)); By End User Analysis (academic & Research Centers, Reference Laboratories, Hospital and Physician Laboratories) and By Regional Analysis – Global Forecast by 2016 - 2022”

How Big is the Global Liquid Biopsy Market?

The Global Liquid Biopsy Market is expected to exceed more than US$ 2 billion by 2022 and will grow at a CAGR of more than 23% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/liquid-biopsy-market

Liquid biopsy is a minimally invasive technology for detection of molecular biomarkers without the need for high priced or invasive processes. It's an easy and non-invasive alternative to surgical biopsies which allows scientific medical doctors to find out a variety of statistics about a ailment or a tumor through a easy blood pattern. Circulating most cancers cells or lines of the cancer’s RNA or DNA in the blood can provide clues about which remedies are most likely to paintings for that affected person. Circulating nucleic acids are protected with the aid of extracellular micro-vesicles, especially exosomes. A test accomplished on a pattern of blood to search for cancer cells from a tumor that are circulating within the blood or for portions of DNA from tumor cells that are in the blood. A liquid biopsy may be used to assist locate cancer at an early degree. It may additionally be used to help plan treatment or to discover how nicely remedy is working or if cancer has come lower back.

The major driving factors of Global Liquid Biopsy Market are as follows:

• Rising new Cancer Cases
• Technical Advancements
• Accessibility of Funding for Liquid Biopsy Research
• Initiatives to raise Awareness on Liquid Biopsy

The restraining factors of Global Liquid Biopsy Market are as follows:

• Low Specificity and Sensitivity

The Global Liquid Biopsy Market is segmented on the lines of its type of cancer, product and service, circulation biomarkers, end user and regional. Based on type on cancer it covers lung cancer, colorectal cancer, prostate cancer, breast cancer, liver cancer and other cancers. Product and service is classified into instruments, services and software and reagents. Under circulation biomarkers it covers circulating tumor cells, extracellular vesicles, circulating tumor DNA and other biomarkers. End user segment is classified into academic & research centers, reference laboratories, hospital and physician laboratories and others end user. The Global Liquid Biopsy Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:

1) An overview of the global market for Liquid Biopsy and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

3) Identifications of new market opportunities and targeted promotional plans for Global Liquid Biopsy Market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.


REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for Global Liquid Biopsy Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Biocept Inc. (U.S.), Myriad Genetics (U.S.), QIAGEN (Netherlands), Roche (Switzerland), Bio-Rad Laboratories Inc. (U.S.), Trovagene Inc. (U.S.), Guardant Health, Inc. (U.S.), Janssen Diagnostics, LLC (U.S.), Fraunhofer-Gesellschaft (Germany), and MDxHealth SA (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Global Liquid Biopsy Market has been segmented as below:

By Type of Cancer Analysis

• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Breast Cancer
• Liver Cancer
• Other Cancers

By Product and services Analysis

• Instruments
• Services and Software
• Reagents

By Circulation Biomarkers Analysis

• Circulating Tumor Cells (CTCs)
• Extracellular Vesicles (EVs)
• Circulating Tumor DNA (ctDNA)
• Other Biomarkers (Circulating RNA and Protein)

By End User Analysis

• academic & Research Centers
• Reference Laboratories
• Hospital and Physician Laboratories
• Others End User

By Regional Analysis

• North America
• Europe
• Asia-Pacific
• Rest of the World

Reasons to Buy this Report:

1) Obtain the most up to date information available on all Global Liquid Biopsy Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Liquid Biopsy Market data.
4) Assess your competitor’s refining portfolio and its evolution.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.